Medline annual ebitda
2023
2024
2025
Medline EBITDA Growth & History (MDLN)
Medline's calculated EBITDA was $3.22B for fiscal 2025.
View full Medline company overviewMedline annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | $3.22B | $100.0M | +3.20% |
| 2024 | 2024-12-31 | $3.12B | $922.0M | +41.89% |
| 2023 | 2023-12-31 | $2.20B | — | — |
Medline quarterly ebitda
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-27 | $651.0M | −$241.0M | −27.02% |
| Q1 2026 | 2026-03-28 | $676.0M | −$142.0M | −17.36% |
| Q4 2025 | 2025-12-31 | $633.0M | — | — |
| Q2 2025 | 2025-06-28 | $892.0M | — | — |
| Q1 2025 | 2025-03-29 | $818.0M | — | — |
Medline ebitda trends
Between the periods ended 2023-12-31 and 2025-12-31, Medline's ebitda increased from $2.20B to $3.22B, a change of $1.02B. The latest reported quarter, Q2 2026, shows $651.0M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medline source filings ↗